Craft

Luminex

Revenue

$417.4 M

FY, 2020

Luminex Summary

Company Summary

Overview
Luminex is a company that develops and manufactures multiplexing technologies for researchers and clinicians. It offers xMap, a technology for detection biomarkers, xTag, a technology for making nucleic acid assay development and optimization, MultiCode, a platform for polymerase chain reaction (PCR) -based assays, etc. The company also offers extraction and cytometry kits, ready mixes, primers, and molecular controls, and other accessories. Luminex caters to clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety markets.
Type
Subsidiary
Status
Active
Founded
1998
HQ
Austin, TX, US | view all locations
Website
https://www.luminexcorp.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Angelo Rago
  • Charles J. Collins

    Charles J. Collins, Senior Vice President, Technology & Innovation

  • Steven Back, VP of Quality Assurance and Management and VP of Manufacturing

Operating MetricsView all

Services Provided

4

Apr, 2023

Technologies

4

Apr, 2023

Instruments

2

Apr, 2023

LocationsView all

10 locations detected

  • Austin, TX HQ

    United States

    12212 Technology Blvd #130

  • Madison, WI

    United States

    1224 Deming Way

  • Northbrook, IL

    United States

    4088 Commercial Ave

  • Seattle, WA

    United States

    645 Elliott Ave W

  • Toronto, Ontario

    Canada

    439 University Ave Suite 900

  • Shanghai, Shanghai Shi

    China

    14/F C&D, Building 7, Pujiang Hi-Tech Park 2388 Chenhang Road, Minhang District

and 4 others

Luminex Financials

Summary Financials

Revenue (Q1, 2021)
$110.7M
Gross profit (Q1, 2021)
$66.5M
Net income (Q1, 2021)
$9.1M
Cash (Q1, 2021)
$271.6M
EBIT (Q1, 2021)
$13.5M

Footer menu